| Dr Laura Beth Cornwell, MD | |
|
4001 Dutchmans Ln, Louisville, KY 40207-4714 | |
| (502) 559-1794 | |
| Not Available |
| Full Name | Dr Laura Beth Cornwell |
|---|---|
| Gender | Female |
| Speciality | Urology - Pediatric Urology |
| Location | 4001 Dutchmans Ln, Louisville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871937979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | A160427 (California) | Secondary |
| 2088P0231X | Urology - Pediatric Urology | 55621 (Kentucky) | Primary |
| Entity Name | Norton Childrens Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326695255 PECOS PAC ID: 3779917596 Enrollment ID: O20200102000758 |
News Archive
In a study that could have significant consequences for neural tissue transplantation strategies, researchers at the Salk Institute for Biological Studies report that inactivating a specific gene in adult neural stem cells makes nerve cells emerging from those precursors form connections in the wrong part of the adult brain.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc. ("FusionVax") setting forth the main terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for Asia.
University of California, Riverside researchers have created a method that can classify different species of insects with up to 99 percent accuracy, a development that could help farmers protect their crops from insect damage and limit the spread of insect-borne diseases, such as malaria and Dengue fever.
La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that it has received a notice from the Nasdaq Stock Market indicating that the Company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Minimum Bid Price Rule") because, for the last 30 consecutive days, the bid price for the Company's common stock has closed below the minimum level of $1.00 per share.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Beth Cornwell, MD Po Box 776879, Chicago, IL 60677-6879 Ph: (502) 588-9490 | Dr Laura Beth Cornwell, MD 4001 Dutchmans Ln, Louisville, KY 40207-4714 Ph: (502) 559-1794 |
News Archive
In a study that could have significant consequences for neural tissue transplantation strategies, researchers at the Salk Institute for Biological Studies report that inactivating a specific gene in adult neural stem cells makes nerve cells emerging from those precursors form connections in the wrong part of the adult brain.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a Memorandum of Understanding (MoU) with FusionVax, Inc. ("FusionVax") setting forth the main terms under which Advaxis will, subject to the entry of a definitive agreement, exclusively license its lead clinical stage product candidate, ADXS-HPV, to FusionVax for Asia.
University of California, Riverside researchers have created a method that can classify different species of insects with up to 99 percent accuracy, a development that could help farmers protect their crops from insect damage and limit the spread of insect-borne diseases, such as malaria and Dengue fever.
La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that it has received a notice from the Nasdaq Stock Market indicating that the Company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Minimum Bid Price Rule") because, for the last 30 consecutive days, the bid price for the Company's common stock has closed below the minimum level of $1.00 per share.
› Verified 3 days ago
Mr. Mohammed Adnan Said, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St Unit 520, Louisville, KY 40202 Phone: 502-588-4740 Fax: 502-588-9537 | |
Dr. Mohammad Amin, MD Urology Medicare: Medicare Enrolled Practice Location: 800 Zorn Ave, Veterans Affairs Medical Center, Louisville, KY 40206 Phone: 502-287-4000 Fax: 502-287-6825 | |
Dr. Kellen Bo Yung Choi, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 401 E Chestnut St Unit 480, Louisville, KY 40202 Phone: 502-588-4740 Fax: 502-588-9537 | |
Ross Micciche, Urology Medicare: Medicare Enrolled Practice Location: 501 E Broadway Ste 270, Louisville, KY 40202 Phone: 502-588-4740 | |
Anthony J. Casale, M.D. Urology Medicare: Medicare Enrolled Practice Location: 234 E Gray St, Suite 662, Louisville, KY 40202 Phone: 502-629-4220 | |
Jamie C. Messer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 234 E Gray St Ste 662, University Of Louisville Department Of Urology, Louisville, KY 40202 Phone: 502-629-4224 Fax: 502-629-4223 | |
Eric R Uhlenhuth, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1900 Bluegrass Ave, Suite 203, Louisville, KY 40215 Phone: 502-375-0009 Fax: 502-375-2150 |